Trademarkia Logo

Australia

AU$
LUMZZI
Cancelled: Cancelled at the request of IB

Last updated on 8 Sept 2023

Owner Info

Alnylam Pharmaceuticals, Inc.

300 Third Street

Cambridge MA 02142, UNITED STATES OF AMERICA

Serial Number

2008381 filed on 29 Mar 2019

Correspondent

Timothy H. Hiebert

Womble Bond Dickinson (US) LLP,

470 Atlantic Avenue, Suite 600,

UNITED STATES OF AMERICA

LUMZZI

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of primary hyperoxaluria.

Mark Details


Serial Number

2008381

Registered On

29 Mar 2019

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

22 Mar 2019

Mark Type

US

Legal History


Show more

Status DateAction Taken
8th Sept 2023Status change to Voided
30th Jul 2020Amendment to International Registration Contact Requested
16th Nov 2019International Registration in Australia Protected correspondence sent
15th Nov 2019IP Right Registration Published
15th Nov 2019Status change to Registered/Protected
9th Sept 2019Application Accepted correspondence sent
8th Sept 2019IP Right Acceptance Published
8th Sept 2019IP Right has been Examined
8th Sept 2019Status change to Accepted
10th May 2019Awaiting examination